Airfinity hosting industry leader roundtable on the future of the RSV market

Posted on Jan 3, 2023

Airfinity is bringing together leading experts to discuss one of the biggest emerging markets in the pharma industry for a live, virtual roundtable.

Hosted by Analytics Director Dr Matt Linley, get an exclusive look at Airfinity's independent forecasts on RSV, which our panel of guest speakers will then explore and discuss key market drivers.

When: Tuesday 31 January, 8am PT / 11am ET / 4pm GMT

Register for free here

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022